Michael Miles
Physician Assistant · Draper, UTNPI 1174175426
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,292, more than ten times the $112 reported in 2021. Among physician assistant clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 180 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$569
- Johnson & Johnson$414
- Neurocrine Biosciences, Inc.$403
- Otsuka America Pharmaceutical, Inc.$400
- Vanda Pharmaceuticals Inc.$298
- Axsome Therapeutics, Inc.$292
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,47997%
- Education$1043%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 37 | $569 |
| Johnson & Johnson | 18 | $414 |
| Neurocrine Biosciences, Inc. | 16 | $403 |
| Otsuka America Pharmaceutical, Inc. | 24 | $400 |
| Vanda Pharmaceuticals Inc. | 12 | $298 |
| Axsome Therapeutics, Inc. | 10 | $292 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $248 |
| Lundbeck LLC | 13 | $244 |
| Alkermes, Inc. | 10 | $202 |
| Teva Pharmaceuticals USA, Inc. | 5 | $164 |
| Idorsia Pharmaceuticals US Inc | 5 | $81 |
| Supernus Pharmaceuticals, Inc. | 5 | $76 |
| Ironshore Pharmaceuticals Inc. | 4 | $63 |
| Bausch Health US, LLC | 2 | $38 |
| Biogen | 2 | $31 |
| Alfasigma USA, Inc. | 1 | $17 |
| GSK | 1 | $15 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
How this compares
$3,584 in reported general payments places this provider in the 90th percentile of 1,543 physician assistant providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 12 | $267 |
| Gabapentin | 22 | $240 |
| Lamotrigine | 14 | $203 |
| Quetiapine Fumarate | 11 | $85 |
| Clonazepam | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Draper
- Regan BrooksSlc$606K
- Keri HolyoakMidvale$438K
- Jill EricksonSalt Lake City$179K
- Vanessa Beard-ElyMurray$80K
- Natalie BeeSalt Lake City$63K
- Jasmin CharlesTaylorsville$46K
- Luke JenkinsWest Jordan$46K
- Chanise FrandsenSandy$31K
- Alexandra RoccoWashington Terrace$31K
- Jenna RhotonOgden$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.